Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

U.S. university and Novartis form global alliance for anticancer T-cell immunotherapies

Aug. 6, 2012

FDA assigns PDUFA action date for enzalutamide NDA

Aug. 6, 2012

Zaltrap approved in U.S. for cancer indication

Aug. 6, 2012

GSK confirms submissions for dabrafenib and trametinib

Aug. 6, 2012

Beta Pharma patents novel protein kinase inhibitors

Aug. 6, 2012

MEK inhibitor improves survival in METRIC trial

Aug. 6, 2012

Pol I inhibitor shows anticancer potency in vitro and in vivo

Aug. 6, 2012

Sirolimus reduces skin cancer occurrence in renal transplant recipients

Aug. 6, 2012

Diffusion Pharmaceuticals completes treatment in first cohort of phase I/II brain cancer trial

Aug. 3, 2012

Two investigator-sponsored cabozantinib trials begin

Aug. 3, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...